Monday, June 27, 2011

Pharmacyclics lymphoma drug shows continued promise

Reuters reports that:
"The latest results from a small, early stage trial of Pharmacyclics Inc's experimental drug for non-Hodgkin's lymphoma showed about 49 percent of patients responded to it, the company said on Saturday."
Read the full story here.

No comments:

Post a Comment